Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AbbVie (ABBV) Announces European Commission's Approval of AQUIPTA®
AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political
Pharmaceutical Stocks To Consider - June 5th - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Westfield Capital Management Co. LP
Vise Technologies Inc. Acquires 25,198 Shares of AbbVie Inc. $ABBV
WCG Wealth Advisors LLC Buys Shares of 17,087 AbbVie Inc. $ABBV
12,757 Shares in AbbVie Inc. $ABBV Bought by Total Wealth Planning & Management Inc.
J.W. Cole Advisors Inc. Cuts Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Prestige Wealth Management Group LLC - Stock Observer
AbbVie (NYSE:ABBV) Shares Unloaded Rep. Josh Gottheimer
Clifford Swan Investment Counsel LLC Sells 3,532 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Stock Unloaded Rep. Josh Gottheimer - Stock Observer
NICE Endorses AbbVie's Elahere for Treating Ovarian Cancer, ETPharma
Elahere's NHS Approval Tests AbbVie's Oncology Expansion And Investor Thesis
AbbVie (NYSE:ABBV) Shares Up 3.5% - Here's What Happened
Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment - Stock Observer
5 Best Cheap Stocks to Buy for Beginners
Greenspring Advisors LLC Grows Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by TD Asset Management Inc
Top Medical Stocks To Research - June 4th - Daily Political
AbbVie Inc. $ABBV Shares Bought by Cibc World Market Inc.
Promising Medical Stocks To Research - June 3rd - Zolmax
Bank of New York Mellon Corp Raises Stock Holdings in AbbVie Inc. $ABBV - Zolmax
AbbVie Delivers 400% Returns Beating The S&P 500 by 139% - AOL
Top 5 High-Yield Dividend Stocks for Income Investors in 2026
This Is What a $1 Million Dividend Portfolio Pays After Taxes
The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of AQUIPTA For Acute Migraine
AbbVie Inc. $ABBV Stock Holdings Increased by BNP Paribas - Stock Observer
Revenue Rises 27.5%; AbbVie Pact Marks Key FY26 Milestone
COFG Advisors LLC Invests $4.09 Million in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Shares Up 1.4% - Here's What Happened - Daily Political
Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells
AbbVie (ABBV) to Attend Goldman Sachs Global Healthcare Conference
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic - AOL
AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®
Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?
17,902 Shares in AbbVie Inc. $ABBV Purchased by COFG Advisors LLC
Glenmark Pharmaceuticals Ltd (BOM:532296) Q4 2026 Earnings Call Highlights: Strong Revenue ...
Access to CAR-T cell therapy in Central and Eastern Europe: persistent barriers and inequalities as of October/November 2025
Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax
Natera And 2 Other Companies That May Be Trading Below Their Estimated Value
AbbVie Inc. $ABBV Shares Bought by Hillsdale Investment Management Inc.
AbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Daily Political
Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Privacy preserving digital platform for patient reported outcomes in inflammatory bowel disease
Botulinum Toxin Drugs Market Demand and Future Opportunities - Express Press Release Distribution
AbbVie Inc. $ABBV Shares Bought by MUFG Securities EMEA plc
Railway Pension Investments Ltd Has $196.44 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Welch & Forbes LLC - Stock Observer
AbbVie Inc. $ABBV Position Increased by MUFG Securities EMEA plc - Daily Political
Investment Analysts' Upgrades for May 30th (A, ABBV, ACA, AFCG, AKAN, ALLR, ALRS, ASUR, AXIA, BILL) - Stock Observer
SBI Okasan Asset Management Co.Ltd. Acquires New Shares in AbbVie Inc. $ABBV - Zolmax
Intech Investment Management LLC Sells 2,467 Shares of AbbVie Inc. $ABBV - Stock Observer
SBI Okasan Asset Management Co.Ltd. Buys New Holdings in AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Raised to Strong-Buy at Wall Street Zen
Norges Bank Takes $5.87 Billion Position in AbbVie Inc. $ABBV - Daily Political
Eurizon Capital SGR S.p.A. Acquires Shares of 1,554,089 AbbVie Inc. $ABBV - Daily Political
AbbVie (ABBV) Expands Venclyxto Label for Chronic Lymphocytic Leukemia Treatment
VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks
AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
Rothschild Investment LLC Reduces Position in AbbVie Inc. $ABBV - Zolmax
AbbVie's VENCLYXTO Label Gets EU Approval For Chronic Lymphocytic Leukemia Treatment
Assessing AbbVie (ABBV) Valuation After FDA Approval Of Decnupaz For Ultra Rare Blood Cancer
Best Pharmaceutical Stocks To Research - May 29th - Daily Political
Savant Capital LLC Sells 22,942 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co
National Pension Service Sells 77,989 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Shares Up 1.5% - Here's What Happened - Zolmax
AbbVie (NYSE:ABBV) Stock Price Up 1.5% - Here's What Happened
Huntington National Bank Buys 17,446 Shares of AbbVie Inc. $ABBV
Is AbbVie (ABBV) Still Attractive After A 21.5% One Year Share Price Gain?
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial
AbbVie (ABBV) Receives FDA Approval for Groundbreaking BPDCN Treatment
Abbvie Gets FDA Approval for Blood Cancer Treatment | Morningstar
AbbVie announces FDA approval of DECNUPAZ
AbbVie (ABBV) Receives FDA Approval for Decnupaz in Rare Cancer Treatment
Ironwood Pharmaceuticals (IRWD) Gains FDA Approval for Linzess in Young Patients
AbbVie Inc. $ABBV Shares Bought by King Luther Capital Management Corp - Zolmax
Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress
Final Trades: AbbVie, Deckers and Goldman Sachs
34,517 Shares in AbbVie Inc. $ABBV Purchased by Seaview Investment Managers LLC - Zolmax
Fisher Asset Management LLC Buys 352,487 Shares of AbbVie Inc. $ABBV
MSH Capital Advisors LLC Boosts Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Raised by Fisher Asset Management LLC
Harbour Investments Inc. Purchases 146,611 Shares of AbbVie Inc. $ABBV - Stock Observer
Is EMA Backing For MAVIRET And Boey Reshaping The Investment Case For AbbVie (ABBV)?
MSH Capital Advisors LLC Increases Holdings in AbbVie Inc. $ABBV - Daily Political
Seaview Investment Managers LLC Acquires Shares of 34,517 AbbVie Inc. $ABBV - Daily Political
AbbVie News
US Monetary Policy Pivot: Non-Farm Payrolls, Inflation Fears, and Potential Rate Hikes
Netanyahu-Trump Rift Exposed: Ceasefire Talks Put Israeli Election Stakes in Jeopardy
US May Jobs Report: A Critical Indicator for the Fed's Interest Rate Path
Latest news
Show moreMarket Pulse: Dollar Rises, Gold Dips Post-US Jobs Data; Geopolitical Tensions Simmer
US May Jobs Report Signals Slowing Growth: A Deep Dive into Market Indicators
Hormuz Strait Oil Tanker Activity Shifts: Increased Secrecy and Market Fragmentation
US May Jobs Report Exceeds Expectations, Bolstering Economic Resilience and Shifting Fed Rate Outlook
